Clinical trial
Prospective Open Randomized Monocentric Two-armed Controlled Clinical Trial in Parallel Groups to Investigate the Influence of Complementary Medicine (CAM) Interventions on Quality of Life and The Treatment Process of Patients Undergoing Allogenic Stem Cell Transplantation
NCT02976558 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Open Randomized Monocentric Two-armed Controlled Clinical Trial in Parallel Groups to Investigate the Influence of Complementary Medicine (CAM) Interventions on Quality of Life and The Treatment Process of Patients Undergoing Allogenic Stem Cell Transplantation
- Lead sponsor
- University of Erlangen-Nürnberg Medical School
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 31, 2016
- Completion date
- December 16, 2019
- Enrollment
- 104 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression, graft-versus-host disease, hematological neoplasm, leukemia, quality of life, stem cell transplant complications